Status:
COMPLETED
The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
1. ry outcome includes the correlation between lymphocyre /neurtophll ratio (LNR) and mortality rate during hospital stay in the ICU admitted COVID 19 patients. 2. ry outcome(s) include the LNR and it...
Detailed Description
In December 2019,the COVID-19 virus has been mainly breaking out in Wuhan in China as pneumonia affecting patients . Common clinical features During hospitalization started to appear including acute r...
Eligibility Criteria
Inclusion
- Adult patients (aged ≥18 years)
- Patients who need non-invasive ventilation (NIV or CPAP) or invasive ventilation (intubation)
Exclusion
- Previous diagnosis of severe liver or kidney failure.
- Patients with Human Immunodeficiency Virus (HIV) infection.
- Patients with previous hematological diseases (Leukemia) that condition alterations in blood counts.
- Consumption of treatments with any type of immunosuppressants prior to admission that conditions low lymphocytes.
- Patients with bone marrow depression.
Key Trial Info
Start Date :
March 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04817397
Start Date
March 20 2021
End Date
August 30 2021
Last Update
October 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt